First Time Loading...

Livzon Pharmaceutical Group Inc
SZSE:000513

Watchlist Manager
Livzon Pharmaceutical Group Inc Logo
Livzon Pharmaceutical Group Inc
SZSE:000513
Watchlist
Price: 40.1 CNY 1.75% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one Livzon Pharmaceutical Group Inc stock under the Base Case scenario is 44.73 CNY. Compared to the current market price of 40.1 CNY, Livzon Pharmaceutical Group Inc is Undervalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
44.73 CNY
Undervaluation 10%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3
P/S
P/S
Price to Sales
3
vs History
33
vs Industry
40
Median 3Y
2.7
Median 5Y
2.8
Industry
2.4
Forward
2.7
More Details
19
P/E
P/E
Price to Earnings
19
vs History
47
vs Industry
26
Median 3Y
17.9
Median 5Y
19
Industry
22.9
Forward
16.7
More Details
11.4
P/OCF
P/OCF
Price to OCF
11.4
vs History
74
vs Industry
33
Median 3Y
14
Median 5Y
14.5
Industry
17.1
More Details
12.5
P/FCFE
P/FCFE
Price to FCFE
12.5
vs History
71
vs Industry
28
Median 3Y
13.2
Median 5Y
15
Industry
23.2
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
33
vs Industry
31
Median 3Y
2.5
Median 5Y
2.6
Industry
2.1
More Details
2.4
EV/S
EV/S
Enterprise Value to Sales
2.4
vs History
34
vs Industry
46
Median 3Y
2.2
Median 5Y
2.3
Industry
2.6
Forward
2.2
More Details
3.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.9
vs History
28
vs Industry
50
Median 3Y
3.5
Median 5Y
3.6
Industry
5.1
More Details
14.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.3
vs History
28
vs Industry
27
Median 3Y
12.9
Median 5Y
13.2
Industry
13.6
Forward
9.7
More Details
14.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
14.3
vs History
28
vs Industry
32
Median 3Y
12.9
Median 5Y
13.2
Industry
17
Forward
11.9
More Details
9.2
EV/OCF
EV/OCF
Enterprise Value to OCF
9.2
vs History
73
vs Industry
39
Median 3Y
11.3
Median 5Y
11.6
Industry
15.8
More Details
12.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
12.4
vs History
74
vs Industry
27
Median 3Y
20
Median 5Y
19.3
Industry
17.6
More Details
2.3
EV/IC
EV/IC
Enterprise Value to IC
2.3
vs History
39
vs Industry
33
Median 3Y
2.1
Median 5Y
2.2
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Livzon Pharmaceutical Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Livzon Pharmaceutical Group Inc
SZSE:000513
37B CNY 3 19 14.3 14.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
697.9B USD 20.5 133.2 60.2 69.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.8T DKK 16.3 45.2 33 36
US
Johnson & Johnson
NYSE:JNJ
357.8B USD 4.4 8.8 11.8 15.5
US
Merck & Co Inc
NYSE:MRK
323.8B USD 5.3 140.4 33.4 53
UK
AstraZeneca PLC
LSE:AZN
186.8B GBP 5.1 39.3 140.6 225.6
CH
Novartis AG
SIX:NOVN
179.8B CHF 4.2 13.3 9.7 16.1
CH
Roche Holding AG
SIX:ROG
172.7B CHF 2.9 15 8.6 10.2
US
Pfizer Inc
NYSE:PFE
155.7B USD 2.7 73.5 11 16.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.